Most Popular

    MacTel SAFE Study

    MacTel SAFE Study

    March 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.   LMRI is conducting the SAFE study (Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum...

    Positive Phase 3 Topline Results Announced for NT-501 Implant in MacTel

    Positive Phase 3 Topline Results Announced for NT-501 Implant in MacTel

    November 2, 2022 Neurotech Pharmaceuticals, Inc. announces positive Phase 3 topline results for NT-501 implant in macular telangiectaisa type 2 (MacTel).  (Cumberland, RI) Clinically relevant and statistically significant primary results with t...

    Phase 3 Trial Currently Enrolling MacTel Patients

    Phase 3 Trial Currently Enrolling MacTel Patients

    Neurotech Pharmaceuticals, with support from the Lowy Medical Research Institute, is currently enrolling a Phase 3 clinical trial testing ciliary neurotrophic factor (CNTF) in patients with macular telangiectasia type 2.  This is a multi-center trial...

    MacTel Project 2021 Update

    MacTel Project 2021 Update

    LOWY MEDICAL RESEARCH INSTITUTE - LMRI This past year has surely been an interesting and challenging one.  We hope that you and your family, friends, neighbors, and coworkers were able to weather the events safely. Despite the many challenges prese...

    Lowy Medical Research Institute scientists find cause of debilitating eye disease

    Lowy Medical Research Institute scientists find cause of debilitating eye disease

    15-year effort points to treatments to help MacTel patients and offers potential new insights into other eye diseases LA JOLLA, CA–September 11, 2019– Scientists at the Lowy Medical Research Institute (LMRI) have discovered one cause of a progre...